Roy Wong-Mc Clure

Dr. Roy Wong-Mc Clure


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2015 in Journal of Diabetes
Verified
Journal Article
Closed access
PDF file
RCRoy Wong-Mc Clure
Roy Wong-Mc Clure
EGEdward W. Gregg
Edward W. Gregg
ABAlberto Barcelo
Alberto Barcelo
LSLaura Sanabria‐Lopez
Laura Sanabria‐Lopez
KLKahye Lee
Kahye Lee
ELElizabeth T. Luman
Elizabeth T. Luman

15 December 2013 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
RCRoy Wong-Mc Clure
Roy Wong-Mc Clure
ERElenita Ramírez-Salas
Elenita Ramírez-Salas
NMNury Mora-Brenes
Nury Mora-Brenes
LALorena Aguero-Sandí
Lorena Aguero-Sandí
MMMaritza Morera-Sigler
Maritza Morera-Sigler
EBElizabeth Bryce
Elizabeth Bryce
Introduction: The C. difficile BI/NAP 1 hyper virulent strain has been responsible for the nosocomial outbreaks in several countries. The present study describes the infection control strategies utilized to achieve outbreak control as well as the factors associated with a C. difficile BI/NAP 1 hyper virulent strain outbreak in Costa Rica. Methodology: A descriptive analysis of the C. difficile outbreak was completed for the period of January 2007 to December 2010 in one affected hospital. An unmatched case-control study was subsequently performed to evaluate the association of exposure factors with C. difficile infection. Results: The pattern of the outbreak was characterized by a sharp increase in the incidence rate during the initial weeks of the outbreak, which was followed by a reduction in the incidence curve as several infection control measures were implemented. The C. difficile BI/NAP1 infection was associated with the prescription of antibiotics, in particular levofloxacin (OR: 9.3; 95%CI: 2.1-40.2), meropenem (OR: 4.9, 95%CI: 1.0-22.9), cefotaxime (OR: 4.3, 95%CI: 2.4-7.7), as well as a medical history of diabetes mellitus (OR: 2.9, 95%CI: 1.5-5.8). Conclusions: The infection control strategies implemented proved to be effective in achieving outbreak control and in maintaining the baseline C. difficile incidence rate following it. The reported C. difficile outbreak was associated with the prescription of broad-spectrum antibiotics and a medical history of diabetes.

1 November 2013
Verified
Closed access
RCRoy Wong-Mc Clure
Roy Wong-Mc Clure
LALeandra Abarca-Gómez
Leandra Abarca-Gómez
XBXiomara Badilla-Vargas
Xiomara Badilla-Vargas
MGMoraima Guevara-Rodríguez
Moraima Guevara-Rodríguez
ASAntonio Solano-Chinchilla
Antonio Solano-Chinchilla
MOMichele O'Shea
Michele O'Shea

14 February 2026 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
ABAlberto Barcelo
Alberto Barcelo
RCRoy Wong-Mc Clure
Roy Wong-Mc Clure
FVFelicia Canete Villalba
Felicia Canete Villalba
ELEthel Santacruz Lezcano
Ethel Santacruz Lezcano
NBNoelia Lorena Cañete Borja
Noelia Lorena Cañete Borja
AGArise Galil
Arise Galil
Background: In the Americas, the number of people living with diabetes is expected to rise from 92 million in 2024 to 120 million by 2050. Indigenous populations may experience distinct biological, environmental, and sociocultural risk factors; however, they are often treated as a homogeneous group in epidemiological research, and consolidated evidence on diabetes prevalence across diverse Indigenous populations remains limited. This scoping review examines the prevalence of diabetes among Indigenous populations in the Americas. Methods: Following PRISMA-ScR guidelines, we conducted a systematic scoping review of population-based studies reporting the prevalence of diabetes among Indigenous adult populations in the Americas. Searches were performed in PubMed and Scopus. Collected data included study location, Indigenous group, population characteristics, diagnostic criteria, and test used and reported prevalence estimates. Results: Sixty documents encompassing 73 studies met the inclusion criteria, representing 45,503 individuals from 16 countries between 1975 and 2025. The total number of ethnic groups represented was 111, and 12 studies did not identify a specific ethnic group. Fasting blood glucose (FBG) was the most frequently used diagnostic method, followed by the oral glucose tolerance test (OGTT). Estimates of the prevalence of diabetes varied widely across populations, regions, and time periods. Five studies—from Brazil, Chile, Colombia, Mexico, and Paraguay—did not identify any cases of diabetes. Among studies reporting cases, prevalence ranged from 1 to 70% in North America, 5 to 14% in Central America, and 1 to 29% in South America. Conclusions: The prevalence of diabetes among Indigenous populations varied widely across the region, with substantially higher estimates reported in North America than in Central and South America. The decline in published studies in recent years suggests reduced research attention to this topic. The marked heterogeneity identified in this review underscores the need for standardized measurement approaches to support population-specific strategies aligned with personalized care and precision public health.

24 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ABAlberto Barcelo
Alberto Barcelo
RCRoy Wong-Mc Clure
Roy Wong-Mc Clure
FVFelicia Canete Villalba
Felicia Canete Villalba
ELEthel Santacruz Lezcano
Ethel Santacruz Lezcano
NBNoelia Lorena Cañete Borja
Noelia Lorena Cañete Borja
AGArise Galil
Arise Galil
Background: Diabetes is a growing public health concern worldwide, with an estimated 537 million people affected in 2021. This number is projected to increase by 46% over the next 25 years. In the Americas, the prevalence of diabetes is expected to rise from 84 million in 2021 to 112 million by 2045. Indigenous populations may face unique risk factors, yet there is limited consolidated data on diabetes prevalence within these communities. This systematic review examines the prevalence of diabetes among Indigenous populations in the Americas. Methods: Following PRISMA-ScR guidelines, a systematic search was conducted in Scopus and PubMed. Studies were included if they reported population-based surveys on diabetes prevalence among Indigenous and mestizo adults in the Americas. Data extraction focused on study location, population characteristics, diagnostic criteria, and reported prevalence. Results: A total of 60 documents, representing 73 studies, met the inclusion criteria and covered 45,503 individuals from 16 countries between 1975 and 2025. Mexico contributed the largest number of studies (17), followed by the United States (15), Brazil (10), Canada (7), Chile (6), and Guatemala (5). Most participants were from North America (29,093), followed by Central America (8,144) and South America (6,911). No eligible reports were identified from Caribbean nations, Peru, or Guyana. In total, 111 Indigenous groups were represented. The most frequently used diagnostic method was fasting blood glucose (FBG), applied in 50 studies (75%), followed by the oral glucose tolerance test (OGTT) in 41 studies (61%). The combined prevalence of diabetes among Indigenous and mestizo populations was 12% overall (17% among women and 14% among men). Mean diabetes prevalence was highest in North America (17%), followed by Central America (8.9%) and South America (4.9%). Notably, five studies—from Brazil, Chile, Colombia, Mexico, and Paraguay—reported no cases of diabetes. Conclusions: The prevalence of diabetes among Indigenous populations in the Americas is highly heterogeneous, with considerably higher rates reported in North America compared with Central and South America. Although genetic predisposition may play an important role, environmental and lifestyle factors likely contribute substantially to these differences. The decline in published studies in recent years suggests a reduction in research focus on this topic. Further investigation into modifiable risk factors—such as diet, physical activity, and socioeconomic conditions—is essential to better understand the epidemiology of diabetes, clarify how these determinants interact, and support the development of targeted interventions to reduce risk and address health disparities among Indigenous populations across the region. Keywords: Diabetes, Indigenous populations, Americas, epidemiology, public health, prevalence, systematic review.